American Century Companies’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRA
BG
WA
MC
RG
American Century Companies's ATRA Position: Q3 2023 in Review
American Century Companies sold out of Atara Biotherapeutics (ATRA) in Q3 2023, closing a stake of 585 shares — an estimated $23.6K sold.
American Century Companies first reported a position in ATRA in Q4 2022 and held it in 3 quarters. The position peaked at $63.3K in Q1 2023. 109 funds tracked by Wall St. Rank hold ATRA as of Q3 2023.
- American Century Companies reported no remaining Atara Biotherapeutics position as of Q3 2023 after selling out during the quarter.
- American Century Companies sold 585 Atara Biotherapeutics shares in Q3 2023, an estimated $23.6K.
- American Century Companies first reported a position in Atara Biotherapeutics in Q4 2022 and held it in 3 quarters.
- American Century Companies's Atara Biotherapeutics position peaked at $63.3K in Q1 2023.
- 109 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2023.
Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.